EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evaluating Activated Regulatory T Cells as a Biomarker of Chronic Allograft Inflammation in Pediatric Kidney Transplant Recipients

Macyn L Leung iD, Ella Barrett-Chan iD, Megan K Levings, Suzanne Vercauteren, Tom D Blydt-Hansen iD

Pediatric Transplantation · 2025

DOI: 10.1111/petr.70041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, 2025. Verfasst von Macyn L Leung und 4 weiteren Autor:innen. Beteiligte Einrichtung: BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Kidney Transplantation, T-Lymphocytes, Regulatory, Inflammation, Graft Rejection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: BC Children's Hospital Foundation, Canadian Donation and Transplantation Research Program, BC Children’s Hospital Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is a need for noninvasive immunological biomarkers that can identify stable kidney allograft immune quiescence to inform individualized immunosuppression.

Methods

We conducted a cross‐sectional, pilot cohort study evaluating the relative abundance of regulatory T cells (Tregs) to effector T‐cell (Teff) populations as a surrogate marker of long‐term graft tolerance. We obtained fresh peripheral blood mononuclear cell samples from stable pediatric kidney transplant recipients, most with recent surveillance biopsies to identify the presence or absence of chronic inflammation. Tregs were sub‐phenotyped as naïve, memory, and activated Tregs (aTreg). Treg/Teff ratios were modeled for association with chronic inflammation and in the context of potential clinical features.

Results

Twenty‐seven patient samples were included on standard immunosuppression (tacrolimus, mycophenolate, and prednisone) with a mean age of 9.2 ± 5.0 years, at 30.2 ± 21.7 months posttransplant. The ratio of aTreg (FOXP3 ++ CD45RA − ) to Th17 cells (CD4 + IL‐17 + ) was significantly greater in patients without inflammation than in patients with graft inflammation ( p < 0.01). Similarly, there was a trend toward greater aTreg/CD4 + T cells and aTreg/CD8 + Teff in patients without inflammation ( p = 0.05 and 0.09, respectively). There was no significant association for inflammation with naïve or memory Treg/Teff ratios. Multiple logistic regression with all three aTreg/Teff ratios modeled allograft inflammation with high sensitivity and specificity (AUC = 0.83, 95% CI 0.67–0.98).

Conclusions

The proportion of peripheral blood aTregs/Teff cells in this pilot cohort of stable pediatric kidney transplant recipients was associated with immune quiescence. These data support further investigation into aTreg/Teff monitoring to inform precision immunosuppressive treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationT-Lymphocytes, RegulatoryInflammationGraft RejectionHumansChildMalePilot ProjectsFemaleBiomarkersCross-Sectional StudiesAdolescentChild, PreschoolImmunosuppressive AgentsChronic DiseaseAllografts

Stichwörter der Autor:innen

Treg/Teffimmune biomarkerskidney transplantationregulatory T cells

Substanzen

BiomarkersImmunosuppressive Agents

Autor:innen und Institutionen

  • BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Macyn L Leung, Ella Barrett-Chan, Tom D Blydt-Hansen

Förderung

  • BC Children's Hospital Foundation
  • Canadian Donation and Transplantation Research Program
  • BC Children’s Hospital Foundation

Zitieren

APA

Leung, M. L., Barrett-Chan, E., Levings, M. K., Vercauteren, S., & Blydt-Hansen, T. D. (2025). Evaluating Activated Regulatory T Cells as a Biomarker of Chronic Allograft Inflammation in Pediatric Kidney Transplant Recipients. Pediatric Transplantation. https://doi.org/10.1111/petr.70041

Vancouver

Leung ML, Barrett-Chan E, Levings MK, Vercauteren S, Blydt-Hansen TD. Evaluating Activated Regulatory T Cells as a Biomarker of Chronic Allograft Inflammation in Pediatric Kidney Transplant Recipients. Pediatric Transplantation. 2025. doi:10.1111/petr.70041

BibTeX
@article{Leung2025,
  author = {Leung, Macyn L and Barrett-Chan, Ella and Levings, Megan K and Vercauteren, Suzanne and Blydt-Hansen, Tom D},
  title = {Evaluating Activated Regulatory T Cells as a Biomarker of Chronic Allograft Inflammation in Pediatric Kidney Transplant Recipients},
  journal = {Pediatric Transplantation},
  year = {2025},
  doi = {10.1111/petr.70041}
}
Kostenlos starten →